Heart Failure
Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
Published in Physician Business Week, November 25th, 2008
The interim Phase II results were presented by John R. Teerlink, M.D., Professor of Medicine, University of California San Francisco, in a satellite symposium at the American Heart Association's (AHA) Scientific Sessions 2008 in New Orleans. The data from the first 209 patients enrolled in the trial demonstrated beneficial trends in acute heart failure (AHF) signs,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- Anesthesia
Team Finance LLC Announces Third Quarter 2008 Results - Aspyra, Inc.
Aspyra to Unveil New Volume-Based PACS and RIS/PACS Pricing at RSNA 2008 - Cancer
Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward - EagleBank Foundation
Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000 - Integrated Healthcare Holdings, Inc.
Chief Executive Officer Leaving Integrated Healthcare Holdings, Inc. - Intelity
Intelity Introduces ICE, the Hotelier's Solution to Increase Revenue and Decrease Expenses While Maintaining Service - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
